Acclarent Secures $26,000,000 Series D Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9788fabd-46c1-44ff-93b5-885a74c68f03&Preview=1 -
Date
1/12/2009 -
Company Name
Acclarent -
Mailing Address
1525-B O’Brien Drive Menlo Park, CA 94025 -
Company Description
Initially, we are focused on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools – Balloon SinuplastyTM devices. Through the Balloon SinuplastyTM technology and our Relieva® product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year. -
Website
http://www.acclarent.com -
Transaction Type
Venture Equity -
Transaction Amount
$26,000,000 -
Transaction Round
Series D -
Proceeds Purposes
Acclarent intends to use the proceeds to continue commercialization of its Balloon Sinuplasty(TM) Technology, as well as on-going investment in product development and clinical studies. -
M&A Terms
-
Venture Investor
Johnson & Johnson Development Corporation -
Venture Investor
New Enterprise Associates -
Venture Investor
Delphi Ventures -
Venture Investor
Versant Ventures -
Venture Investor
Meritech Capital Partners
